Ten-year outcomes after percutaneous coronary intervention with drug-eluting stents for bifurcation lesions: insights from the DECADE cooperation

Patients treated with percutaneous coronary intervention (PCI) for bifurcation lesions have an increased risk of recurrent cardiac events. However, there are limited data on long-term outcomes after PCI with drug-eluting stents (DES) for bifurcation lesions. We sought to compare the long-term outcomes after DES PCI for bifurcation and non-bifurcation lesions among patients included in the Adverse Events and Coronary Artery Disease Progression (DECADE) cooperation, a pooled analysis of individual patient data from randomized controlled trials on DES platforms with a follow-up of 10 years. In the current analysis, patients undergoing PCI with DES were grouped according to whether the treated lesion was classified as a bifurcation or not. The main outcomes were cardiovascular death, myocardial infarction (MI) and target lesion revascularization (TLR) through to 10 years after PCI. Among the total of 6,617 patients included in this study, 1,580 patients underwent PCI of at least one bifurcation lesion and 5,037 patients underwent PCI of non-bifurcation lesions. Through to 10-year follow-up, cardiovascular death (adjusted hazard ratio [HRadj], 1.08 [95% CI, 1.03–1.14]) and TLR (HRadj, 1.50 [95% CI, 1.46–1.53]) occurred significantly more often after bifurcation PCI than after non-bifurcation PCI. Patients receiving a bifurcation PCI had a higher risk of MI at 10 years (HRadj, 1.42 [95% CI, 1.12–1.80]), with the highest risk within 30 days after PCI (HRadj, 2.14 [95% CI, 1.90–2.42]). In conclusion, patients who receive a PCI with a DES for a bifurcation lesion are at an increased risk of cardiovascular death, MI and TLR at 10-year follow-up. 10-year cardiovascular death risk is significantly higher after bifurcation PCI. Early MI rates are higher after bifurcation PCI, long-term MI rates are comparable. Rates of repeat revascularization are significantly higher after bifurcation PCI.

Authors

Institutions

Publication Details

Journal
Cardiovascular Intervention and Therapeutics
Published
2026-09-10
DOI
https://doi.org/10.1007/s12928-026-01332-9
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Ten-year outcomes after percutaneous coronary intervention with drug-eluting stents for bifurcation lesions: insights from the DECADE cooperation

Constantin Kuna, Salvatore Cassese, Karl-Ludwig Laugwitz, J.J. Coughlan et al.
Cardiovascular Intervention and Therapeutics
Coronary Interventions and Diagnostics
article

Ten-year outcomes after percutaneous coronary intervention with drug-eluting stents for bifurcation lesions: insights from the DECADE cooperation

Constantin Kuna, Salvatore Cassese, Karl-Ludwig Laugwitz, J.J. Coughlan, Stephan Windecker, Dik Heg, Lorenz Räber, Fiorenzo Simonetti, Laura Huber, Adnan Kastrati
article en

Abstract

Patients treated with percutaneous coronary intervention (PCI) for bifurcation lesions have an increased risk of recurrent cardiac events. However, there are limited data on long-term outcomes after PCI with drug-eluting stents (DES) for bifurcation lesions. We sought to compare the long-term outcomes after DES PCI for bifurcation and non-bifurcation lesions among patients included in the Adverse Events and Coronary Artery Disease Progression (DECADE) cooperation, a pooled analysis of individual patient data from randomized controlled trials on DES platforms with a follow-up of 10 years. In the current analysis, patients undergoing PCI with DES were grouped according to whether the treated lesion was classified as a bifurcation or not. The main outcomes were cardiovascular death, myocardial infarction (MI) and target lesion revascularization (TLR) through to 10 years after PCI. Among the total of 6,617 patients included in this study, 1,580 patients underwent PCI of at least one bifurcation lesion and 5,037 patients underwent PCI of non-bifurcation lesions. Through to 10-year follow-up, cardiovascular death (adjusted hazard ratio [HRadj], 1.08 [95% CI, 1.03–1.14]) and TLR (HRadj, 1.50 [95% CI, 1.46–1.53]) occurred significantly more often after bifurcation PCI than after non-bifurcation PCI. Patients receiving a bifurcation PCI had a higher risk of MI at 10 years (HRadj, 1.42 [95% CI, 1.12–1.80]), with the highest risk within 30 days after PCI (HRadj, 2.14 [95% CI, 1.90–2.42]). In conclusion, patients who receive a PCI with a DES for a bifurcation lesion are at an increased risk of cardiovascular death, MI and TLR at 10-year follow-up. 10-year cardiovascular death risk is significantly higher after bifurcation PCI. Early MI rates are higher after bifurcation PCI, long-term MI rates are comparable. Rates of repeat revascularization are significantly higher after bifurcation PCI.

Cardiovascular Intervention and Therapeutics
University of Bern (CH), University Hospital of Bern (CH), TUM Klinikum (DE), Deutsches Herzzentrum der Charité (DE), German Centre for Cardiovascular Research (DE), Mater Private Hospital (AU), Technical University of Munich (DE), University of Naples Federico II (IT)
Openalex Percentile: Top 8%
Coronary Interventions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.